Skip to content

STUDY ON THE EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC TREATMENT FOR BENIGN POSITIONAL VERTIGO IN THE AGE GROUP OF 40-70YRS

A PROSPECTIVE STUDY TO ASSESS THE EFFICACY OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN THE MANAGEMENT OF BENIGN PAROXYSMAL POSITIONAL VERTIGO IN AGE GROUP OF 45-65YRS USING VERTIGO SYMPTOM SCALE - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099259
Enrollment
52
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H811- Benign paroxysmal vertigo

Interventions

Intervention1: Individualized Homoeopathic Medicine: The intervention involves the administration of individualized homoeopathic remedy in 30th potency, to individuals suffering from benign paroxysmal
one dose as per requirement of the case. The treatment aims to reduce the frequency and intensity of vertiginous symptoms, as measured by the VSS-SF(Vertigo Symptom Scale Short form). The remedy will

Sponsors

Dr Akshata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects which are positive in Dix Hallpike Test i.e. those who get only vertigo symptom after performing maneuver. Individuals who are also already diagnosed with BPPV. Subjects who score more than 6.5 on Vertigo symptom scale

Exclusion criteria

Exclusion criteria: Subjects having history of head trauma or previous surgery (stapedectomy) and Other secondary causes of vertigo such as Meniere disease, vestibular neuronitis, infections, migraine. Patients with history of cerebrovascular disease or any systemic illness such as hypertension, diabetes. Pregnant and lactating women Patients who are already taking conventional treatment or Epley maneuver for BPPV Those who show only nystagmus after Dix Hallpike Test

Design outcomes

Primary

MeasureTime frame
Reduction of more than or equal to three points from the baseline score on VSS-SF after giving individualized homoeopathic medicines.Timepoint: Baseline (Day 0) & Last Follow up (Day180)

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Jyothi Vijaykumar

AM Shaikh Homoeopathic Medical College And Hospital Belgaum

Jyothivijaykumar3@yahoo.co.in9964357653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026